Veradigm Inc. (NASDAQ:MDRX) Given Consensus Rating of “Hold” by Analysts

Shares of Veradigm Inc. (NASDAQ:MDRX) have received an average recommendation of “Hold” from the five research firms that are presently covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $12.00.

Separately, StockNews.com started coverage on shares of Veradigm in a research note on Friday. They set a “hold” rating for the company.

Veradigm Stock Down 1.5 %

NASDAQ MDRX opened at $9.26 on Tuesday. The business’s 50-day simple moving average is $9.51 and its 200-day simple moving average is $9.17. Veradigm has a 1-year low of $5.01 and a 1-year high of $13.62.

Hedge Funds Weigh In On Veradigm

A number of institutional investors and hedge funds have recently bought and sold shares of MDRX. Innealta Capital LLC purchased a new stake in shares of Veradigm during the second quarter valued at approximately $38,000. Meadow Creek Wealth Advisors LLC purchased a new stake in Veradigm during the 1st quarter worth $83,000. Tyro Capital Management LLC acquired a new position in Veradigm in the 1st quarter worth $9,055,000. Finally, Vanguard Group Inc. boosted its position in Veradigm by 0.7% in the 4th quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock valued at $149,754,000 after buying an additional 95,291 shares during the last quarter.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.